Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015, Article ID 651803, 4 pages
http://dx.doi.org/10.1155/2015/651803
Case Report

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis

Division of Pediatric Nephrology, Okinawa Prefectural Nanbu Medical Center-Children’s Medical Center, Arakawa 118-1, Haebaru, Okinawa 901-1193, Japan

Received 16 December 2014; Revised 3 February 2015; Accepted 3 February 2015

Academic Editor: Nan-Chang Chiu

Copyright © 2015 Tomoo Kise et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Chan, F. K. Li, C. S. O. Tang et al., “Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group,” The New England Journal of Medicine, vol. 343, no. 16, pp. 1156–1162, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. E. M. Ginzler, M. A. Dooley, C. Aranow et al., “Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis,” The New England Journal of Medicine, vol. 353, no. 21, pp. 2219–2228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. B. Appel, G. Conteras, M. A. Dooley et al., “Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis,” Journal of the American Society of Nephrology, vol. 20, pp. 1103–1112, 2009. View at Publisher · View at Google Scholar
  4. J. Cortés-Hernández, M. T. Torres-Salido, A. S. Medrano, M. V. Tarrés, and J. Ordi-Ros, “Long-term outcomes—mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases,” Nephrology Dialysis Transplantation, vol. 25, no. 12, pp. 3939–3948, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. M. Lanata, T. Mahmood, D. M. Fine, and M. Petri, “Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis,” Lupus, vol. 19, no. 8, pp. 935–940, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Bao, Z.-H. Liu, H.-L. Xie, W.-X. Hu, H.-T. Zhang, and L.-S. Li, “Successful treatment of class V+IV lupus nephritis with multitarget therapy,” Journal of the American Society of Nephrology, vol. 19, no. 10, pp. 2001–2010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Mok, C. H. To, K. L. Yu, and L. Y. Ho, “Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study,” Lupus, vol. 22, no. 11, pp. 1135–1141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. J. Pons-Estel, R. Serrano, M. A. Plasín, G. Espinosa, and R. Cervera, “Epidemiology and management of refractory lupus nephritis,” Autoimmunity Reviews, vol. 10, no. 11, pp. 655–663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. A. Austin III, G. G. Illei, M. J. Braun, and J. E. Balow, “Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy,” Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 901–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Dalton, M. Smith, and J. M. Thurman, “The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease,” Nephrol Dial Transplant Plus, vol. 3, no. 4, pp. 346–348, 2010. View at Publisher · View at Google Scholar · View at Scopus